Reminder: DOT expanding drug testing to include opioids on Jan. 1, 2018
Tags : DOT Compliance
The U.S. Department of Transportation (DOT) recently posted an additional notice in anticipation of the upcoming Jan. 1, 2018 effective date.
The notice is available here.
As a reminder, the DOT is expanding their existing drug testing panel – which consists of marijuana, cocaine amphetamines, phencyclidine (PCP) and opiates – to include testing for four semi-synthetic opioids. The four semi-synthetic opioids are hydrocodone, hydromorphone, oxymorphone and oxycodone. Some common names for these semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid® and Exalgo®.
Companies that are covered by the DOT should amend their drug testing programs accordingly prior to Jan. 1, 2018.
Source: Transportation.gov, 12/11/2017
What Our Clients Are Saying
The service you provide at Truescreen has been the best I have ever seen in comparison to other vendors I have worked with in the past! You guys rock!
I am very impressed with your company’s customer service, and the Truescreen portal seems to be an intuitive, user-friendly design.
Our team loves working with Truescreen and the expedient, thorough service and results we get from you.
I appreciate all your hard work ensuring that individuals are cleared through our processes. Truescreen makes my job so much easier and less stressful.